Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole. 1976

H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's

Related Publications

H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
November 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
November 1975, Surgery, gynecology & obstetrics,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
February 1976, Cancer treatment reports,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
January 1978, Cancer research,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
August 1992, The Urologic clinics of North America,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
January 1977, Canadian journal of surgery. Journal canadien de chirurgie,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
May 2021, Vaccines,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
August 1992, The Urologic clinics of North America,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
May 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
H R Shibata, and L M Jerry, and M G Lewis, and P W Mansell, and A Capek, and G Marquis
May 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
Copied contents to your clipboard!